Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a confirmed cancer diagnosis
- People who are scheduled to receive platinum-based chemotherapy followed by surgery to remove the bladder
- People whose kidneys and heart are functioning well enough to safely receive platinum-based chemotherapy
Who may not be able to join:
- People who have previously received chemotherapy or radiotherapy for bladder cancer
- People who have serious heart, kidney, liver, breathing, or metabolic health conditions
- People who are pregnant or breastfeeding
- People who have uncontrolled health conditions that could affect the results of the study (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jill M Hamilton-Reeves, PhD, RD, CSO, University of Kansas Medical Center
Phone: 913-588-7650
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To assess Resting Energy Expenditure (REE) changes across key treatment milestones.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.